hC Bioscience Overview
- Founded
- 2021
- Status
- Private
- Latest Deal Type
- Series A
- Latest Deal Amount
- $24M
- Investors
- 3
hC Bioscience General Information
Description
Developer of tRNA therapy drugs designed to correct multiple mutant proteins in a variety of disease indications. The company's approach for protein editing advances beyond genome editing to direct modification of the proteome, serving healthcare as an innovator and pioneer of protein editing and providing a translation of genetic code into the proteins to overcome disease-causing issues.
Contact Information
Website
www.hcbioscience.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Primary Office
- One Broadway
- 14th Floor
- Cambridge, MA 02142
- United States
+1 (617) 000-0000
hC Bioscience Timeline
hC Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 23-Feb-2022 | $24M | 0000 | Completed | Startup | |
| 1. Early Stage VC | 17-Dec-2021 | 0000 | 0000 | 0000 | Completed | Startup |
hC Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 00,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 000 |
hC Bioscience Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| David Altreuter Ph.D | Chief Technology Officer | ||
| Leslie Williams | Co-Founder, Chief Executive Officer, President & Board Member |
hC Bioscience Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| David Moskowitz | 8VC | Board Member | 000 0000 |
| Leslie Williams | Self | Co-Founder, Chief Executive Officer, President & Board Member | 000 0000 |
| Sacha Mann | Takeda Ventures | Board Member | 000 0000 |
| Steven Gillis Ph.D | ARCH Venture Partners | Chairman Of Board | 000 0000 |
hC Bioscience Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| 8VC | Venture Capital | Minority | 000 0000 | 000000 0 | |
| ARCH Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Takeda Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |